Aptamer Sciences Inc (KOSDAQ:291650)
1,228.00
-63.00 (-4.88%)
At close: May 18, 2026
Aptamer Sciences Market Cap
Aptamer Sciences has a market cap or net worth of 49.44 billion as of May 19, 2026. Its market cap has increased by 80.57% in one year.
Market Cap
49.44B
Enterprise Value
39.96B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,228.00
Market Cap Chart
Since September 16, 2020, Aptamer Sciences's market cap has decreased from 234.93B to 49.44B, a decrease of -78.96%. That is a compound annual growth rate of -24.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 49.44B | 62.01% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 69.07B |
| Quratis | 66.19B |
| Progen | 63.65B |
| EyeGene | 62.64B |
| HLB Pep | 61.34B |
| Psomagen | 59.73B |
| J2KBIO | 59.24B |
| ADBiotech | 48.90B |